SCHEMBL644629

SCHEMBL644629

CCOc1c2ccccc2cc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.44
HTR2A P28223 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SLC2A1 P11166 1/20 0.43
NR1I2 O75469 1/20 0.42
BTK Q06187 1/20 0.41
TLR8 Q9NR97 1/20 0.41
ALOX5 P09917 1/20 0.41
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40
TUBA1A Q71U36 1/20 0.40
TUBA1C Q9BQE3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29694174 1.00 GPR84 (0.44) GPR84HTR2AL3MBTL1SLC2A1NR1I2
Boric Acid SCHEMBL28924899 0.92 SLC2A1 (0.43) GPR84HTR2AL3MBTL1SLC2A1NR1I2
SCHEMBL23089898 0.88 CYP2A6 (0.42) GPR84L3MBTL1SLC2A1NR1I2ALOX5
SCHEMBL28274935 0.88 L3MBTL1 (0.43) L3MBTL1SLC2A1TUBB4ATUBBTUBA3C
SCHEMBL23089943 0.86 CYP1A2 (0.50) GPR84SLC2A1NR1I2BTKALOX5
SCHEMBL23089971 0.86 POLB (0.44) GPR84L3MBTL1SLC2A1NR1I2ALOX5
SCHEMBL23089905 0.86 CYP2A6 (0.41) GPR84HTR2ASLC2A1NR1I2BTK
SCHEMBL2250811 0.85 ALOX5 (0.36) GPR84HTR2AL3MBTL1SLC2A1NR1I2
SCHEMBL2254017 0.85 SLC2A1 (0.36) GPR84HTR2AL3MBTL1SLC2A1NR1I2
SCHEMBL16680272 0.85 KIF11 (0.41) GPR84HTR2ASLC2A1NR1I2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110407984-A A kind of viscosity reduction fluorescent type poly carboxylic acid series water reducer and preparation method thereof JIANGSU ARIT NEW MAT CO LTD 2019-11-05 CN claimed
EP-4745668-A1 PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMATION METHOD, AND METHOD FOR PRODUCING LAMINATE TOKYO OHKA KOGYO CO., LTD. (JP) 2026-05-20 EP disclosed
CN-122070516-A Negative photosensitive composition, photosensitive resist film, method for producing hollow structure, and method for forming pattern 东京应化工业株式会社 2026-05-19 CN disclosed
US-12631963-B2 Method for producing hollow package and method for providing photosensitive composition TOKYO OHKA KOGYO CO., LTD. (JP) 2026-05-19 US disclosed
WO-2026100268-A1 NEGATIVE PHOTOSENSITIVE FILM, MULTILAYER FILM, DRY FILM, AND NEGATIVE PHOTOSENSITIVE COMPOSITION 東京応化工業株式会社 2026-05-15 WO disclosed
US-12624392-B2 Molecular array generation using photoresist 10X GENOMICS, INC. (US) 2026-05-12 US disclosed
EP-4722199-A1 AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2026-04-08 EP disclosed
US-12422747-B2 Negative photosensitive resin composition, pattern formation method, and laminated film SAN-APRO LTD. (JP) 2025-09-23 US disclosed
US-20250170800-A1 PRODUCTION METHOD FOR HOLLOW STRUCTURE, LAMINATE TOKYO OHKA KOGYO CO., LTD. (JP) 2025-05-29 US disclosed
WO-2025094787-A1 NEGATIVE PHOTOSENSITIVE COMPOSITION, PHOTOSENSITIVE RESIST FILM, METHOD FOR PRODUCING HOLLOW STRUCTURE, AND PATTERN FORMING METHOD 東京応化工業株式会社 2025-05-08 WO disclosed
EP-0284868-B1 Photoresist compositions MICROSI INC (US) 1995-05-03 EP disclosed
US-5362607-A Photo-patternable in absence of moisture; treating substrate with positive resist composition, baking, irradiating resist in patterned way, heating, developing; resist of water-soluble phenolic resin, tertiary butyl compound, aryl onium salt MICROSI, INC. (US) 1994-11-08 US disclosed
US-5340697-A Comprising light sensitive triazine, acid-crosslinkable material, and alkali soluble esin FUJI PHOTO FILM CO., LTD. (JP) 1994-08-23 US disclosed
US-5310619-A Resist compositions comprising a phenolic resin, an acid forming onium salt and a tert-butyl ester or tert-butyl carbonate which is acid-cleavable MICROSI, INC. (US) 1994-05-10 US disclosed
EP-0439816-B1 PROCESS FOR OBTENTION OF CYCLOHEXENE FROM MIXTURES CONTAINING CYCLOHEXENE, BENZENE AND/OR CYCLOHEXANE BASF Aktiengesellschaft (DE) 1993-09-01 EP disclosed
EP-0541112-A1 Positive type light-senstitive composition FUJI PHOTO FILM CO., LTD. (JP) 1993-05-12 EP disclosed
EP-0439816-A1 Process for obtention of cyclohexene from mixtures containing cyclohexene, benzene and/or cyclohexane BASF Aktiengesellschaft (DE) 1991-08-07 EP disclosed
EP-0284868-A2 Photoresist compositions MicroSi, Inc. (a Delaware corporation) (US) 1988-10-05 EP disclosed
EP-0249139-A2 Resist compositions and use MicroSi, Inc. (a Delaware corporation) (US) 1987-12-16 EP disclosed
US-4603101-A Photoresist compositions containing t-substituted organomethyl vinylaryl ether materials GENERAL ELECTRIC COMPANY (US) 1986-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12422747-B2 Negative photosensitive resin composition, pattern formation method, and laminated film H1-10, PUF60, IGLV6-57 GPR84 2018/4885HTR2A 2869/4885L3MBTL1 3340/4885
US-12624392-B2 Molecular array generation using photoresist POLL, LIG4, LIG3 GPR84 3405/4885HTR2A 1677/4885L3MBTL1 358/4885
US-12631963-B2 Method for producing hollow package and method for providing photosensitive composition ASH2L, AS3MT, ASH1L GPR84 3839/4885HTR2A 4389/4885L3MBTL1 629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.